Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the complete record of transactions filed by Boctor Fady. Director active across 1 company, notably Petros Pharmaceuticals, Inc.. Aggregated, 4 disclosures have been recorded. History available since 21 December 2023. The latest transaction was disclosed on 5 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Boctor Fady is a declarant linked to Petros Pharmaceuticals, Inc. on XNAS, with the role listed as See Remarks. The record shows 4 filings in total, all within the sampled set, over the period from 2023-12-26 to 2026-06-05, with buy and sell amounts stated as 0 and a modal transaction nature of Attribution.